It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BTSG’s FA Score shows that 0 FA rating(s) are green while.
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BTSG’s TA Score shows that 4 TA indicator(s) are bullish.
BTSG (@Services to the Health Industry) experienced а -0.59% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +3.51%. For the same industry, the average monthly price growth was +4.64%, and the average quarterly price growth was +24.48%.
BTSG is expected to report earnings on Oct 29, 2026.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| BTSG | RB | |
|---|---|---|
| RSI ODDS (%) | N/A | 7 days ago 40% |
| Stochastic ODDS (%) | 3 days ago 90% | 3 days ago 23% |
| Momentum ODDS (%) | 3 days ago 60% | 3 days ago 53% |
| MACD ODDS (%) | N/A | 3 days ago 8% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 69% |
| TrendMonth ODDS (%) | 3 days ago 70% | 3 days ago 67% |
| Advances ODDS (%) | 7 days ago 90% | 30 days ago 56% |
| Declines ODDS (%) | 3 days ago 71% | N/A |
| BollingerBands ODDS (%) | 3 days ago 89% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TNA | 74.54 | 1.04 | +1.41% |
| Direxion Daily Small Cap Bull 3X ETF | |||
| PJFM | 67.73 | N/A | N/A |
| PGIM Jennison Focused Mid-Cap ETF | |||
| LGDX | 24.56 | N/A | N/A |
| Intech S&P Large Cap Diversified Alpha ETF | |||
| AJUL | 30.37 | -0.02 | -0.08% |
| Innovator Eq Dfnd Prot ETF - 2Yr toJul28 | |||
| IMF | 52.47 | -0.10 | -0.18% |
| Invesco Managed Futures Strategy ETF | |||
A.I.dvisor tells us that RB and HUT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RB and HUT's prices will move in lockstep.